GlassScriptPhysician profile
Earl M Darby
NPI 1790743292
$3,485.80
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,477 · 2020: $1,109 · 2021: $881 · 2022: $19.43.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $844.25 | 2019-2022 | |
| Gilead Sciences, INC. | $626.48 | 2019-2021 | |
| Janssen Biotech, INC. | $488.20 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $359.32 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $197.07 | 2019-2020 | |
| Daiichi Sankyo INC. | $175.37 | 2019-2021 | |
| Shionogi INC | $116.33 | 2019-2020 | |
| Cook Medical LLC | $110.11 | 2020 | |
| Pfizer INC. | $90.20 | 2019 | |
| Braintree Laboratories, INC. | $69.63 | 2019-2021 | |
| Intercept Pharmaceuticals, INC. | $58.79 | 2019-2020 | |
| Redhill Biopharma INC. | $57.15 | 2020 | |
| Endo Pharmaceuticals INC. | $55.79 | 2019 | |
| Merck Sharp & Dohme LLC | $55.28 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $47.89 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $41.38 | 2020 | |
| Allergan, INC. | $38.43 | 2019-2020 | |
| Vivus LLC | $24.01 | 2019 | |
| Ironwood Pharmaceuticals, INC | $17.49 | 2021 | |
| Ucb, INC. | $12.63 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Earl Darby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.